Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $1.7M
- Enterprise value
- $1.7M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $0.67
- 52-wk low
- $0.02
- Beta
- —
- Shares out
- 4.5M
5-year trend
What this company does
Overview Glucose Health, Inc. was incorporated under the laws of the State of Nevada on March 27, 2007. Our principal executive office is located at 609 SW 8th Street, Suite 600, Bentonville, AR 72712 and our telephone number is 479-802-3827. Our corporate website is www.glucosehealthinc.com, and our product website is www.glucosehealth.com. Our CUSIP number is 379894108 and trading symbol is GLUC. We are a manufacturer of dietary supplements formulated to help maintain healthy blood sugar, triglycerides and cholesterol and digestive health, and our business focus is serving the consumer market segment of persons concerned about pre-diabetes and/or Type-2 diabetes. As discussed in greater…
AI summary unavailable — showing raw filing excerpt
Generated from GLUC's filing dated 2017-03-29
Key risks
The company qualifies as a smaller reporting company and is not required to provide the information required by this Item.
AI summary unavailable — showing raw filing excerpt
Generated from GLUC's filing dated 2017-03-29
Earnings tracker
Not enough quarterly history for GLUC yet to draw an earnings tracker.
Industry trend
Medicinal Chemicals & Botanical Products · SIC 2833
Your notes
Keep private notes on GLUC — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for GLUC in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns GLUC
No institutional holdings on file for GLUC yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once GLUC's latest filing finishes processing.